These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24942029)

  • 21. Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.
    Marsh RA; Rao K; Satwani P; Lehmberg K; Müller I; Li D; Kim MO; Fischer A; Latour S; Sedlacek P; Barlogis V; Hamamoto K; Kanegane H; Milanovich S; Margolis DA; Dimmock D; Casper J; Douglas DN; Amrolia PJ; Veys P; Kumar AR; Jordan MB; Bleesing JJ; Filipovich AH
    Blood; 2013 Feb; 121(6):877-83. PubMed ID: 23131490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFNɣ Block, Treosulfan Conditioning and αβ T Cell Deplete PBSCT for XIAP-Deficient HLH.
    O'Rafferty C; Velangi M; Lawson S; Hiwarkar P; Motwani J
    J Clin Immunol; 2017 Aug; 37(6):511-513. PubMed ID: 28639166
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT.
    Mickelson DM; Sproat L; Dean R; Sobecks R; Rybicki L; Kalaycio M; Pohlman B; Sweetenham J; Andresen S; Bolwell B; Copelan EA
    Bone Marrow Transplant; 2011 Jan; 46(1):84-9. PubMed ID: 20305699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
    Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
    Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
    Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.
    Marsh RA; Villanueva J; Zhang K; Snow AL; Su HC; Madden L; Mody R; Kitchen B; Marmer D; Jordan MB; Risma KA; Filipovich AH; Bleesing JJ
    Cytometry B Clin Cytom; 2009 Sep; 76(5):334-44. PubMed ID: 19288545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
    Hirshfeld E; Weiss L; Kasir J; Zeira M; Slavin S; Shapira MY
    Bone Marrow Transplant; 2006 Sep; 38(5):359-64. PubMed ID: 16862165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failure.
    Mohamedbhai SG; Edwards N; Morris EC; Mackinnon S; Thomson KJ; Peggs KS
    Br J Haematol; 2012 Feb; 156(4):516-22. PubMed ID: 22171699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation.
    Seidel MG; Fritsch G; Matthes-Martin S; Lawitschka A; Lion T; Pötschger U; Rosenmayr A; Fischer G; Gadner H; Peters C
    Haematologica; 2005 Oct; 90(10):1405-14. PubMed ID: 16219578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis.
    Cesaro S; Gazzola MV; Marson P; Calore E; Caenazzo L; Destro R; De Silvestro G; Varotto S; Pillon M; Zanesco L; Messina C
    Am J Hematol; 2003 Feb; 72(2):143-6. PubMed ID: 12555220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
    Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M
    Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XIAP deficiency in hematopoietic recipient cells drives donor T-cell activation and GvHD in mice.
    Müller N; Fischer JC; Yabal M; Haas T; Poeck H; Jost PJ
    Eur J Immunol; 2019 Mar; 49(3):504-507. PubMed ID: 30585320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma.
    Levenga H; Schaap N; Maas F; Esendam B; Fredrix H; Greupink-Draaisma A; de Witte T; Dolstra H; Raymakers R
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):320-32. PubMed ID: 19835972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis.
    Steele CL; Doré M; Ammann S; Loughrey M; Montero A; Burns SO; Morris EC; Gaspar B; Gilmour K; Bibi S; Shendi H; Devlin L; Speckmann C; Edgar DM
    J Clin Immunol; 2016 Oct; 36(7):733-8. PubMed ID: 27492372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency.
    Yang L; Booth C; Speckmann C; Seidel MG; Worth AJJ; Kindle G; Lankester AC; Grimbacher B; ; Gennery AR; Seppanen MRJ; Morris EC; Burns SO
    J Allergy Clin Immunol; 2022 Aug; 150(2):456-466. PubMed ID: 34920033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children.
    Jacobsohn DA; Duerst R; Tse W; Kletzel M
    Lancet; 2004 Jul 10-16; 364(9429):156-62. PubMed ID: 15246728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients.
    Satwani P; Jin Z; Duffy D; Morris E; Bhatia M; Garvin JH; George D; Bradley MB; Harrison L; Petrillo K; Schwartz J; Foley S; Hawks R; Baxter-Lowe LA; Cairo MS
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):552-61. PubMed ID: 23253557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
    Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
    Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis.
    Hartz B; Marsh R; Rao K; Henter JI; Jordan M; Filipovich L; Bader P; Beier R; Burkhardt B; Meisel R; Schulz A; Winkler B; Albert MH; Greil J; Karasu G; Woessmann W; Corbacioglu S; Gruhn B; Holter W; Kühl JS; Lang P; Seidel MG; Veys P; Löfstedt A; Ammann S; Ehl S; Janka G; Müller I; Lehmberg K
    Blood; 2016 Jun; 127(25):3281-90. PubMed ID: 27099148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.